Dharmanol Update 01-23-14 from Berkeley Bio (100%
Post# of 36728
Posted On: 01/23/2014 11:52:45 AM
Dharmanol Update 01-23-14 from Berkeley Bio (100% owned sub of SKTO)
Hi Everyone,
It is almost ready for release. We have finalized the inert ingredients in the tableting mixture and are pleased with the taste. Reworking these ingredients over the last three weeks has held up the printing of the labels several times, but it now seems that everything is correctly in place for the run.
We have done considerable testing of the Dharmanol by distributing a number of test tablets to friends in the MMJ community in the Bay Area and LA. The results of the tests have been very encouraging, many people reporting approximately the same results = no high, but a subtle, somewhat euphoric feeling of good health and well-being. We have noted that these effects are far more pronounced in those who do not medicate daily with active THC. (This is exactly as expected because the function of low-dose Dharmanol therapy is to stimulate and activate the internal endo-cannabinoid system, which activates other health-promoting internal systems.)
I would like to thank those who have helped us with testing the Dharmanol. You help is very much appreciated.
Dave
https://www.facebook.com/berkeleybio
Hi Everyone,
It is almost ready for release. We have finalized the inert ingredients in the tableting mixture and are pleased with the taste. Reworking these ingredients over the last three weeks has held up the printing of the labels several times, but it now seems that everything is correctly in place for the run.
We have done considerable testing of the Dharmanol by distributing a number of test tablets to friends in the MMJ community in the Bay Area and LA. The results of the tests have been very encouraging, many people reporting approximately the same results = no high, but a subtle, somewhat euphoric feeling of good health and well-being. We have noted that these effects are far more pronounced in those who do not medicate daily with active THC. (This is exactly as expected because the function of low-dose Dharmanol therapy is to stimulate and activate the internal endo-cannabinoid system, which activates other health-promoting internal systems.)
I would like to thank those who have helped us with testing the Dharmanol. You help is very much appreciated.
Dave
https://www.facebook.com/berkeleybio
(0)
(0)SK3 Group Inc. (SKTO) Stock Research Links
Scroll down for more posts ▼